Provider: View Press Release
Type: Link
Title: ViiV Healthcare to present new data from diverse portfolio and pipeline of 2-drug and long-acting regimens for HIV treatment and prevention at IAS 2021 | GSK
Description: Data to be presented underscore the commitment to developing innovative treatment and prevention options
Provider: View Press Release
Type: Link
Title: GSK announces positive headline results from five Phase 3 studies of daprodustat for patients with anaemia due to chronic kidney disease | GSK
Description: Full results to be presented at a medical meeting later this year
Provider: View Press Release
Type: Link
Title: GSK unveils plan for one of Europe’s largest life science campuses in Stevenage | GSK
Description: Plan aims to unlock up to £400 million of new private investment and create up to 5,000 new highly-skilled jobs over next decade.
Provider: View Press Release
Type: Link
Title: New study shows more needs to be done to raise public awareness on the impact of good oral health habits on overall health | GSK
Description: A new study by Ipsos and GSK Consumer Healthcare reveals the need to improve public awareness of the benefits of good oral health.
Provider: View Press Release
Type: Link
Title: GSK and Alector announce global collaboration in immuno-neurology for two clinical stage first-in-class monoclonal antibodies for neurodegenerative diseases | GSK
Description: GSK and Alector to co-develop progranulin-elevating monoclonal antibodies, AL001 and AL101, for a range of neurodegenerative diseases
Provider: View Press Release
Type: Link
Title: Elliott Advisors (UK) letter to GSK | GSK
Description: The Board of GSK notes the letter issued by Elliott Advisors (UK) Limited (“Elliott”) on 1 July